Not applicableUnknownNCT02992990What this trial is testingBladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and GradeWho this might be right forBladder Cancer Baylor College of Medicine 30
Large-scale testing (Phase 3)Active Not RecruitingNCT03022825What this trial is testingQUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder CancerWho this might be right forBladder Cancer ImmunityBio, Inc. 190
Testing effectiveness (Phase 2)UnknownNCT04060459What this trial is testingPaclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder CancerWho this might be right forBladder Cancer Third Military Medical University 50
Testing effectiveness (Phase 2)Study completedNCT04383743What this trial is testingPembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder CancerWho this might be right forStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8Muscle Invasive Bladder Carcinoma University of Washington 17
Testing effectiveness (Phase 2)WithdrawnNCT03832673What this trial is testingPembrolizumab-Epacadostat Combination to Treat Muscle-invasive Bladder UrotheLIAl canceR: PECULIAR StudyWho this might be right forMuscle-invasive Bladder Cancer Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Not applicableStudy completedNCT00829920What this trial is testingThe Effect of Treatment on Circulating Tumor Cells in Bladder Cancer Patients With Muscle-invasive or Advanced DiseaseWho this might be right forBladder Cancer University of Colorado, Denver 44
Not applicableStudy completedNCT05939856What this trial is testingLymph Node Dissection Before or After CystectomyWho this might be right forBladder Cancer Jagiellonian University 50
Testing effectiveness (Phase 2)UnknownNCT05957757What this trial is testingRC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 ExpressionWho this might be right forNon-Muscle Invasive Bladder CancerHER2 RenJi Hospital 20
Not applicableUnknownNCT05626101What this trial is testingSafety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized StudyWho this might be right forNon-muscle-invasive Bladder Cancer Al-Azhar University 280
Testing effectiveness (Phase 2)Active Not RecruitingNCT02845323What this trial is testingNeoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the BladderWho this might be right forUrothelial CarcinomaBladder Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06623162What this trial is testingSasanlimab As Maintenance Treatment Based on Clinical Response to Neoadjuvant Treatment in Molecularly Categorized Muscle Invasive Bladder Cancer PatientsWho this might be right forMibcMuscle Invasive Bladder Cancer Fundación de investigación HM 70
Testing effectiveness (Phase 2)Study completedNCT02177695What this trial is testingS1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder CancerWho this might be right forBladder Cancer SWOG Cancer Research Network 237
Not applicableAvailableNCT06443944What this trial is testingAn Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCGWho this might be right forNon-Muscle Invasive Bladder CancerUrothelial CarcinomaUrologic Cancer+1 more CG Oncology, Inc.
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07414992What this trial is testingRadiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder CancerWho this might be right forBladder Urothelial Carcinoma Memorial Sloan Kettering Cancer Center 44
Early research (Phase 1)WithdrawnNCT04109092What this trial is testingStimulator of Interferon Genes (STING) Agonist E7766 in Non-muscle Invasive Bladder Cancer (NMIBC) Including Participants Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy, INPUT-102Who this might be right forUrinary Bladder Neoplasms Eisai Inc.
Not applicableLooking for participantsNCT07379281What this trial is testingEvaluating the Efficacy of Neoadjuvant Chemotherapy Drugs Based on Organoid TechnologyWho this might be right forBladder Cancer Qilu Hospital of Shandong University 254
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05356351What this trial is testingAn Open-label, Single-arm, Multicenter Phase II Clinical Study： Evaluating RC48-ADC Combined With Triplizumab in the Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder CancerWho this might be right forNeoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cance Tianjin Medical University Cancer Institute and Hospital 30
Not applicableWithdrawnNCT04583553What this trial is testingComparative Microbial Analysis of Cystitis in Non-muscle-invasive Bladder Cancer Patients Using Vikor Scientific Urine-ID Testing Menu (IDTM) and Standard Laboratory CultureWho this might be right forUrinary Tract InfectionsBladder Cancer University of Kansas Medical Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06227065What this trial is testingPrecise Neoadjuvant Chemoresection of Low Grade NMIBCWho this might be right forBladder CancerNon-muscle Invasive Bladder CancerLow-risk University of Bern 28
Not applicableLooking for participantsNCT07202819What this trial is testingEffect of Neoadjuvant Chemotherapy on MRI Accuracy Before CystectomyWho this might be right forMuscle Invasive Bladder Cancer Assiut University 76